Significantly, genetically or pharmacologically activating Hh signalling has been reported to ameliorate colitis by inducing the expression of IL-10 in Hh-responsive stromal cells, which subsequently increases the amount of CD4+Foxp3+ regulatory T cells [59]. This evidence concerns the gene FOXP3 and colitis.